Can the findings of recent randomized trials of treatment or no treatment of gestational diabetes be used for changing current treatment approaches?
The U.S. Preventative Services Task Force recently concluded that there was inadequate evidence available to recommend treatment of gestational diabetes mellitus (GDM) largely on the basis of inadequate prospective studies. However one randomized controlled trial and one large prospective cohort have been published since indicating benefits of GDM treatment and harms of mild hyperglycemia. This paper examines these new findings in the context of rising global obesity.
Moore
Thomas R
TR
Department of Reproductive Medicine, University Of California San Diego for School of Medicine, 200 W. Arbor Dr., San Diego, CA 92103, USA. trmoore@ucsd.edu
D001315:Australia; D048909:Diabetes Complications / Q000453:epidemiology; D016640:Diabetes, Gestational / Q000628:therapy*; D005260:Female; D006801:Humans; D009520:New Zealand; D009765:Obesity / Q000150:complications / Q000453:epidemiology; D011247:Pregnancy; D011295:Prenatal Care / Q000379:methods* / Q000639:trends; D016032:Randomized Controlled Trials as Topic